Mortality News and Research

RSS

Research findings show high potential to save neonatal live births in remote settings

Training community birth attendants in rural Zambia in a simple newborn resuscitation protocol reduced neonatal deaths by nearly 50 percent - a finding that shows high potential to save lives in similar remote settings, a team of Boston University School of Public Health international health researchers is reporting.

4 Feb 2011

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and react by attacking the cells in the patient's body.

4 Feb 2011

Study hopes to establish health benefits from cocoa and vitamin C

A study which hopes to establish the health benefits from cocoa and vitamin C is looking for volunteers. Researchers at The University of Nottingham are trying to find ways of helping us maintain muscle mass as we grow old and want to hear from healthy men aged between 18-28 and 65-75.

4 Feb 2011

Congress moves to consider foreign aid spending cuts

On Thursday, House Republicans are expected to "announce fiscal 2011 spending caps," CQ reports. "Budget Chairman Paul D. Ryan, R-Wis., is slated to reveal the top-line discretionary spending limits ... for the remainder of the fiscal year under unprecedented power that the GOP majority gave him in January. House leaders have said they are aiming to make $55 billion to $60 billion in cuts, while a more conservative faction is pushing for $100 billion in cuts. It is unclear where Ryan's numbers will fall," the publication reports.

4 Feb 2011

Immune protein exacerbates skin cancer due to sun exposure: Study

An unexpected immune protein exacerbates cancer due to sun exposure, report researchers in the January 27th issue of Nature. The study suggests that drugs blocking the protein might halt tumor growth in skin cancer patients.

3 Feb 2011

Longer life with osteoporosis therapy: Study

In a new breakthrough, Australian scientists have identified the “remarkable” life-extending properties of an osteoporosis treatment. The research is published in the Journal of Endocrinology and Metabolism on Thursday.

3 Feb 2011

New concrete actions on cancer prevention in Europe

ECCO and its partners are joining forces with the European Commission and MEPs to put forward concrete actions on cancer prevention, to national and EU policymakers in Brussels on 2 February, ahead of World Cancer Day on 4 February.

3 Feb 2011

Bisphosphonates help people with osteoporosis gain extra 5 years of life

Australian clinical researchers have noted an extraordinary and unexpected benefit of osteoporosis treatment - that people taking bisphosphonates are not only surviving well, better than people without osteoporosis, they appear to be gaining an extra five years of life. These findings are published in the Journal of Clinical Endocrinology and Metabolism, now online.

3 Feb 2011

HMORN, iSAEC collaborate to enroll subjects in SAE research project using EMR database

The International Serious Adverse Events Consortium announced today a new collaboration with the HMO Research Network to enroll subjects in research to identify genetic markers that may help predict risk associated with a range of serious drug-related adverse events.

3 Feb 2011

ImmunoCellular Therapeutics initiates enrollment in ICT-107 Phase II trial for GBM

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, announced today that the first patient has been enrolled in its Phase II trial of ICT-107 at the New Jersey Neuroscience Institute at JFK Medical Center. ICT-107 is the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).

3 Feb 2011

Study finds contradictory role of RIP1 protein in the liver during sepsis

Researchers from Rhode Island Hospital have identified a protein that plays a dual role in the liver during sepsis. The protein, known as RIP1, acts both as a "death switch" and as a pro-survival mechanism. The ability to identify the triggers for these functions may play a key role in treating sepsis in the future. The study is published online in advance of print in the journal Shock.

3 Feb 2011

Isis commences ISIS-FXIRx Phase 1 study for treatment of clotting disorders

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.

2 Feb 2011

New state scorecard finds geographic disparities in health insurance coverage for children

Two years after the reauthorization and expansion of the Children's Health Insurance Program, a new Commonwealth Fund state-by-state scorecard evaluating how the health care system is working for children finds that federal and state action on behalf of children has helped preserve, and even expand, health coverage for this group, despite the severe recession.

2 Feb 2011

Masimo PVI predicts fluid responsiveness with high sensitivity, specificity in ICU patients

Masimo announced today that a new study published in the peer-reviewed journal Critical Care Medicine demonstrates that noninvasive, continuous monitoring of Masimo Pleth Variability Index predicts fluid responsiveness with high sensitivity and specificity in mechanically-ventilated patients in the Intensive Care Unit.

2 Feb 2011

Economists suggest new approach to monitor nutrition, child mortality in developing countries

In a paper published in the January issue of the journal Economics and Human Biology, a team of applied economists including William A. Masters, a professor at the Friedman School of Nutrition Science and Policy at Tufts University, suggests a new approach to monitoring the relationship between nutrition and child mortality in developing countries.

2 Feb 2011

Mortality News and Research

Research findings show high potential to save neonatal live births in remote settings

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

Study hopes to establish health benefits from cocoa and vitamin C

Congress moves to consider foreign aid spending cuts

Immune protein exacerbates skin cancer due to sun exposure: Study

Longer life with osteoporosis therapy: Study

New concrete actions on cancer prevention in Europe

Bisphosphonates help people with osteoporosis gain extra 5 years of life

HMORN, iSAEC collaborate to enroll subjects in SAE research project using EMR database

ImmunoCellular Therapeutics initiates enrollment in ICT-107 Phase II trial for GBM

Study finds contradictory role of RIP1 protein in the liver during sepsis

Isis commences ISIS-FXIRx Phase 1 study for treatment of clotting disorders

New state scorecard finds geographic disparities in health insurance coverage for children

Masimo PVI predicts fluid responsiveness with high sensitivity, specificity in ICU patients

Economists suggest new approach to monitor nutrition, child mortality in developing countries

Strategies to improve care include targeting hospital spending, reducing hospital infections

Study finds treatment-related mortality with bevacizumab in cancer patients

Nutritional supplements and seniors: New study

New compound appears to prevent pain crises in sickle cell disease: GHSU

Elsevier announces publication of two position statements from EMAS in Maturitas journal

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News